Note 8. License and Sublicense Agreements

9 Months Ended

Sep. 30, 2011

License And Sublicense Agreements [Text Block]

8. License and Sublicense Agreements.  During the first six months of 2011 no license fees were received.  On August 21, 2011, the Company entered into the Option for License Agreement and Technology Transfer between Amarillo Biosciences and Colorado Serum Company, a $50,000 sublicense fee was received.  The Business Objective is to achieve the successful commercialization of products containing bovine or other animal cytokines (Extract) for human and animal health.  The term of the option for Colorado Serum Company to pursue an exclusive license with the Company is one year from the execution date of the agreement.